Biliverdin reductase-A protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 4, 2011, Pages 480-487

  Barone, Eugenio ^a,b   Di Domenico, Fabio ^a,c   Cenini, Giovanna ^a   Sultana, Rukhsana ^a   Cini, Chiara ^c   Preziosi, Paolo ^b   Perluigi, Marzia ^c   Mancuso, Cesare ^b   Butterfield, D Allan ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Alzheimer disease; Biliverdin reductase; Cerebellum; Hippocampus; Mild cognitive impairment; Oxidative stress

Indexed keywords

BILIVERDIN; BILIVERDIN REDUCTASE A; BRAIN PROTEIN; SERINE; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BILIVERDIN REDUCTASE A BRAIN LEVEL; BRAIN LEVEL; CEREBELLUM; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; ENZYME REGULATION; FEMALE; HIPPOCAMPUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; MILD COGNITIVE IMPAIRMENT; NEUROPATHOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; UPREGULATION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BRAIN; COGNITION; ENZYME ACTIVATION; FEMALE; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OXIDATIVE STRESS; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHOSPHOSERINE; PHOSPHOTHREONINE; PHOSPHOTYROSINE; UP-REGULATION;

EPICOCCUM;

EID: 79551569963     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.01.005     Document Type: Article

References (39)

1. Butterfield D.A., Stadtman E.R. Protein oxidation processes in aging brain. Advances in Cell Aging and Gerontology 1997, 161-191. S.T. Paula, E.E. Bittar (Eds.).
2. Calabrese V., Cornelius C., Mancuso C., Barone E., Calafato S., Bates T., Rizzarelli E., Kostova A.T. Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front. Biosci. 2009, 14:376-397.
3. Mancuso C., Scapagini G., Curro D., Giuffrida Stella A.M., De Marco C., Butterfield D.A., Calabrese V. Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front. Biosci. 2007, 12:1107-1123.
4. Poon H.F., Calabrese V., Scapagnini G., Butterfield D.A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J. Gerontol. A Biol. Sci. Med. Sci. 2004, 59:478-493.
5. Maines M.D. The heme oxygenase system: a regulator of second messenger gases. Annu. Rev. Pharmacol. Toxicol. 1997, 37:517-554.
6. Maines M.D. The heme oxygenase system and its functions in the brain. Cell. Mol. Biol. (Noisy-le-grand) 2000, 46:573-585.
7. Mancuso C. Heme oxygenase and its products in the nervous system. Antioxid. Redox Signal. 2004, 6:878-887.
8. Maines M.D., Panahian N. The heme oxygenase system and cellular defense mechanisms. Do HO-1 and HO-2 have different functions?. Adv. Exp. Med. Biol. 2001, 502:249-272.
9. Maines M.D. The heme oxygenase system: update 2005. Antioxid. Redox Signal. 2005, 7:1761-1766.
10. Kapitulnik J., Maines M.D. Pleiotropic functions of biliverdin reductase: cellular signaling and generation of cytoprotective and cytotoxic bilirubin. Trends Pharmacol. Sci. 2009, 30:129-137.
11. Maines M.D. New insights into biliverdin reductase functions: linking heme metabolism to cell signaling. Physiology (Bethesda) 2005, 20:382-389.
12. Franklin E.M., Browne S., Horan A.M., Inomata K., Hammam M.A., Kinoshita H., Lamparter T., Golfis G., Mantle T.J. The use of synthetic linear tetrapyrroles to probe the verdin sites of human biliverdin-IXalpha reductase and human biliverdin-IXbeta reductase. FEBS J. 2009, 276:4405-4413.
13. Dwyer B.E., Nishimura R.N., Lu S.Y. Differential expression of heme oxygenase-1 in cultured cortical neurons and astrocytes determined by the aid of a new heme oxygenase antibody. Response to oxidative stress. Brain Res. Mol. Brain Res. 1995, 30:37-47.
14. Ewing J.F., Weber C.M., Maines M.D. Biliverdin reductase is heat resistant and coexpressed with constitutive and heat shock forms of heme oxygenase in brain. J. Neurochem. 1993, 61:1015-1023.
15. Lerner-Marmarosh N., Shen J., Torno M.D., Kravets A., Hu Z., Maines M.D. Human biliverdin reductase: a member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity. Proc. Natl Acad. Sci. USA 2005, 102:7109-7114.
16. Lerner-Marmarosh N., Miralem T., Gibbs P.E., Maines M.D. Human biliverdin reductase is an ERK activator; hBVR is an ERK nuclear transporter and is required for MAPK signaling. Proc. Natl Acad. Sci. USA 2008, 105:6870-6875.
17. Tudor C., Lerner-Marmarosh N., Engelborghs Y., Gibbs P.E., Maines M.D. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin. Biochem. J. 2008, 413:405-416.
18. Maines M.D. Biliverdin reductase: PKC interaction at the cross-talk of MAPK and PI3K signaling pathways. Antioxid. Redox Signal. 2007, 9:2187-2195.
19. Calabrese V., Sultana R., Scapagnini G., Guagliano E., Sapienza M., Bella R., Kanski J., Pennisi G., Mancuso C., Stella A.M., Butterfield D.A. Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid. Redox Signal. 2006, 8:1975-1986.
20. Mueller C., Zhou W., Vanmeter A., Heiby M., Magaki S., Ross M.M., Espina V., Schrag M., Dickson C., Liotta L.A., Kirsch W.M. The heme degradation pathway is a promising serum biomarker source for the early detection of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:1081-1091.
21. Kimpara T., Takeda A., Yamaguchi T., Arai H., Okita N., Takase S., Sasaki H., Itoyama Y. Increased bilirubins and their derivatives in cerebrospinal fluid in Alzheimer's disease. Neurobiol. Aging 2000, 21:551-554.
22. Mancuso C., Barone E. The heme oxygenase/biliverdin reductase pathway in drug research and development. Curr. Drug Metab. 2009, 10:579-594.
23. Petersen R.C. Mild cognitive impairment clinical trials. Nat. Rev. Drug Discov. 2003, 2:646-653.
24. Jicha G.A., Parisi J.E., Dickson D.W., Johnson K., Cha R., Ivnik R.J., Tangalos E.G., Boeve B.F., Knopman D.S., Braak H., Petersen R.C. Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia. Arch. Neurol. 2006, 63:674-681.
25. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
26. Cenini G., Sultana R., Memo M., Butterfield D.A. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease. Free Radic. Biol. Med. 2008, 45:81-85.
27. Salim M., Brown-Kipphut B.A., Maines M.D. Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation. J. Biol. Chem. 2001, 276:10929-10934.
28. Pereira P.J., Macedo-Ribeiro S., Párraga A., Pérez-Luque R., Cunningham O., Darcy K., Mantle T.J., Coll M. Structure of human biliverdin IXbeta reductase, an early fetal bilirubin IXbeta producing enzyme. Nat. Struct. Biol. 2001, 8:215-220.
29. Keller J.N., Schmitt F.A., Scheff S.W., Ding Q., Chen Q., Butterfield D.A., Markesbery W.R. Evidence of increased oxidative damage in subjects with mild cognitive impairment. Neurology 2005, 64:1152-1156.
30. Markesbery W.R. Neuropathologic alterations in mild cognitive impairment: a review. J. Alzheimers Dis. 2010, 19:221-228.
31. Aksenov M., Aksenova M.V., Harris M.E., Hensley K., Butterfield D.A., Carney J.M. Enhancement of beta-amyloid peptide A beta(1-40)-mediated neurotoxicity by glutamine synthetase. J. Neurochem. 1995, 65:1899-1902.
32. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenov M., Aksenova M., Gabbita S.P., Wu J.F., Carney J.M., Butterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology and biomarkers of protein oxidation. J. Neurochem. 1995, 65:2146-2156.
33. Barone E., Trombino S., Cassano R., Sgambato A., De Paola B., Di Stasio E., Picci N., Preziosi P., Mancuso C. Characterization of the S-denitrosylating activity of bilirubin. J. Cell. Mol. Med. 2009, 13:2365-2375.
34. Mancuso C., Bonsignore A., Capone C., Di Stasio E., Pani G. Albumin-bound bilirubin interacts with nitric oxide by a redox mechanism. Antioxid. Redox Signal. 2006, 8:487-494.
35. Hyman B.T., Elvhage T.E., Reiter J. Extracellular signal regulated kinases. Localization of protein and mRNA in the human hippocampal formation in Alzheimer's disease. Am. J. Pathol. 1994, 144:565-572.
36. Trojanowski J.Q., Mawal-Dewan M., Schmidt M.L., Martin J., Lee V. Localization of the mitogen activated protein kinase ERK2 in Alzheimer's disease neurofibrillary tangles and senile plaque neurites. Brain Res. 1993, 618:333-337.
37. Perez N., Sugar J., Charya S., Johnson G., Merril C., Bierer L., Perl D., Haroutunian V., Wallace W. Increased synthesis and accumulation of heat shock 70 proteins in Alzheimer's disease. Brain Res. Mol. Brain Res. 1991, 11:249-254.
38. Premkumar D.R., Smith M.A., Richey P.L., Petersen R.B., Castellani R., Kutty R.K., Wiggert B., Perry G., Kalaria R.N. Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J. Neurochem. 1995, 65:1399-1402.
39. Di Domenico F., Sultana R., Tiu G.F., Scheff N.N., Perluigi M., Cini C., Butterfield D.A. Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease. Brain Res. 2010, 1333:72-81.